Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer
Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer
Recruiting · NCT06519292 · Registry updated 2025-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer | Arterial Occlusive Diseases, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, brain disorder, cancer, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, coronary artery disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, neoplasm, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not stated | 2025-05-22 | NCT06519292 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amsterdam UMC | 35 |
| Hanneke W. M. van Laarhoven | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Amsterdam UMC | Amsterdam | Netherlands | 12 |